Shares of Viatris Inc. VTRS slipped 1.03% to $10.62 Monday, on what proved to be an all-around positive trading session for ...

Shares of Viatris Inc. VTRS rose 1.89% to $10.80 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.04% to 6,115.07 and the ...

Biocon aims to grow through new product launches in generics and biosimilars, bolstered by the Viatris acquisition. This ...

David Einhorn's Greenlight Capital opened new positions in Centene (CNC), with about 871K shares, and Acadia Healthcare ...

Let’s dig into the relative performance of Amphastar Pharmaceuticals (NASDAQ:AMPH) and its peers as we unravel the now-completed Q3 generic pharmaceuticals earnings season. The generic pharmaceutical ...

Pancreatic enzyme replacement therapy (Pert) provides the enzymes people affected by pancreatic cancer need to absorb ...

Davis Selected Advisers' 13F portfolio saw changes with stake increases in tech and travel, while reducing in financial and ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at ANI Pharmaceuticals (NASDAQ:ANIP) and its peers. The generic ...

Occasionally, treatments come along that are of greater interest to patients than to doctors.Drops for treating presbyopia ...

Open to individuals, startups, and institutions worldwide, the ADGHW Innovation Award recognises innovations that enhance ...